SODIUM 2-HYDROXYBUTYRATE
CAS No. 5094-24-6
SODIUM 2-HYDROXYBUTYRATE( 2-Hydroxybutyric acid sodium salt | DL-2-Hydroxybutyric Acid Sodium Salt | alpha-hydroxybutyrate )
Catalog No. M19761 CAS No. 5094-24-6
2-Hydroxybutyric acid is formed as a by-product of the formation of alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alpha-hydroxybutyrate dehydrogenase (alphaHBDH).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 26 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSODIUM 2-HYDROXYBUTYRATE
-
NoteResearch use only, not for human use.
-
Brief Description2-Hydroxybutyric acid is formed as a by-product of the formation of alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alpha-hydroxybutyrate dehydrogenase (alphaHBDH).
-
Description2-Hydroxybutyric acid is formed as a by-product of the formation of alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alpha-hydroxybutyrate dehydrogenase (alphaHBDH).
-
In Vitro——
-
In Vivo——
-
Synonyms2-Hydroxybutyric acid sodium salt | DL-2-Hydroxybutyric Acid Sodium Salt | alpha-hydroxybutyrate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5094-24-6
-
Formula Weight126.09
-
Molecular FormulaC4H7NaO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILES[Na+].CCC(O)C([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gall WE et al. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One. 2010 May 28;5(5):e10883.
molnova catalog
related products
-
6-Chloropurine
6-Chloropurine is a building block in chemical synthesiswith?Antitumor activities.
-
MM0299
MM0299 is brain permeable, has anti-glioblastoma activity, inhibits lanosterol synthase (LSS), and induces EPC production in in situ GBM tumors.
-
Burosumab
Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
Cart
sales@molnova.com